Colorado State University photo
Dr. Stephanie McGrath, a veterinary neurologist, is the first researcher to receive significant independent funding in the U.S. to document the therapeutic potential of cannabis in dogs.
More than five years after the first states legalized recreational marijuana, leading to a proliferation of cannabis products for pets and people alike, momentum is building to scientifically document whether cannabis makes good medicine for veterinary patients.
In the first study to attract substantial independent funding in the United States, a neurologist at Colorado State University College of Veterinary Medicine & Biomedical Sciences has begun enrolling patients in a clinical trial to test the effects of the cannabis compound cannabidiol on 60 epileptic dogs who respond poorly to standard treatment. The American Kennel Club Canine Health Foundation (AKC CHF) has awarded the research $356,022.
At Auburn University College of Veterinary Medicine in Alabama, the director of the clinical pharmacology laboratory also plans a clinical trial of cannabidiol in epileptic patients, along with other cannabis-related research. Her work has received $150,000 in analytical